GMP IMPLEMENTATION STRATEGIES -...
Transcript of GMP IMPLEMENTATION STRATEGIES -...
GMPIMPLEMENTATIONSTRATEGIES-MALAYSIA
DrNorya5AbuAminDirector,Na5onalBloodCentre
Na5onalHeadTransfusionMedicineService,MOH
Outline• Countrybackground• DevelopmentofBTSincludingqualitysysteminMalaysia
• Na5onalBloodPolicy• Na5onalsta5s5csonBTS• Lessonslearnt• Priorityforac5on
• Popula5on:30million• Dualhealthsystem-publicandprivate• Healthsystemchallenges-NCDincreasing,emergingandreemergingofinfec5onsandagingpopula5on-sustainabilityofthesystem• Rateofdona5ons:23per1000• Collec5on2015>700,000units• NoofRecipients>388,000(MOH)• Adequateforfreshcomponentsneeds• Seasonalshortages-responsivepublic• Plasmaforfrac5ona5on>32,000kg
COUNTRYBACKGROUND
Public&PrivateSectorResourcesandWorkload(2014&2015)
Source:HealthInformaRcsCenter(HIC),FamilyHealthDevelopmentDivision,NHMS2015,MNHAPrelim(2014)
26.4
29,895
16,622,744
43,822
150
57,069,523
768
23.9
12,290
3,873,935
13,797
291
37,939,354
6,978
0% 20% 40% 60% 80% 100%
Health Expenditure RM Billion (2014)
Doctors(excl. Houseman) (2014)
Bed Days (NHMS 2015)
Hospital Beds (2014)
No. of Hospitals (2014)
Outpatient visits (NHMS 2015)
Health clinics (with doctors) (2014)
Public Private
10%
60%
34% 66%
40%
90%
76%
81%
24%
19%
71%
52%
29%
48%
• 1950s:Bloodbankingac5vitybeganinGHKL• 1972:NBTSlaunched,hospitalbasedblood
banks• 1974:allhospitalsprovidedwithinstruc5on
bookletsontheprocedures-reques5ngofblood,transportandstorageofbloodinwards,thetransfusionofbloodandtherepor5ngandmanagementoftransfusionreac5ons.
• EstablishedtheearliestQualityManagementprinciplesinthelaboratoryandatcri5calpointsbetweentherequestforabloodcomponentandtheactualtransfusionincludingrecordsfromdonorstopa5ents
DevelopmentofBTSinMalaysia(1)
DevelopmentofBTSinMalaysia(2)• Standardizedprin5ngoflabelsandrecordformsforall
transfusionproceduresforallhospitalsinthecountry.• Centralpurchasingandsupplyofconsumables,reagents
andsta5onarycarriedoutbytheCentralMedicalStoreinGHKualaLumpuranddistributedna5onwide.
• 1980-newstandardizedproceduresfortransfusionservice
DevelopmentofBTSinMalaysia(3)• Na5onalindicatorssince1980’s• Proficiencytes5ng:na5onalEQA
programmesince80’s• 1991:Ini5a5onofcontractfrac5ona5on
andbeginningofqualitymanagement,includingGMPinBTS-ongoingauditbyCSL5lltoday
• ISOcer5fica5onsince1995• 1997:Blueprintforana5onally
coordinatedbloodtransfusionservice• 1998:Re-organiza5onandplanfor
regionaliza5onapproved• 2000:EstablishmentoftheNa5onalBlood
Centreandconsolida5onofac5vi5es
32
DevelopmentofBTSinMalaysia(4)• Haemovigilancesince2003
• NATAAccredita5onoftheNa5onalBloodCentrein2004• Implementa5onofNa5onalQualityManagementProgramme
inBTS–ongoingawareness,training,auditbyNBC• 2006:EstablishmentofTransfusionMedicineMMed
Programme• Accredita5onofhospitallaboratoriesbyDepartmentof
StandardsMalaysiasince2009forISO15189• Accredita5onofhospitalsbyMSQH• 2007:NATimplementa5on,currentlycovering60%of
collec5on• Consolida5onofac5vi5es-– 145MOHhospitalsandins5tu5ons-bloodcollec5onin128hospitals,
componentprocessingin20hospitalsandTTIscreeningin15hospitals– Transfusionlaboratory(XM)in349hospitalsincludingprivate
Na;onalBloodPolicy-2008• S5pulategovt.support&commitment• Definesprinciplesðics
– Procurementofbloodfromvoluntarynon-remuneratedblooddonors
– Mandatoryscreeningtest:HIV,HBV,HCVandSyphilis.– Onlyscreenedbloodtobetransfused– Allbloodbanksshouldbeundertheperviewof– amedicalprac55oner.– Blooddonorcriteria;regularreviewofcriteria,no
discrimina5onofanykind– Qualitymanagementsystem/GoodManufacturingPrac5ces
employedinallprocessandprocedure• Sourceoffunding• Clearlydefineroles&responsibili5es• Na5onalguidelinesisbeingupdatedandprinted
• 2014:Upgradingof22centresaspartofna5onalfrac5ona5onprogrammeandtheGMPinspec5onof22bloodcentresbyNPRA
• 2015:2regionalcentresapprovedunder10thMalaysianPlan–SabahandKedah
• Recogni5onofTransfusionMedicineasadis5nctspecialty,2016-nowwith34gazeiedTransfusionMedicineSpecialists
• Broadbasedmul5disciplinaryspecialtywith3mainareas:1. Blooddona;onandsupply
• Behavioural,socialsciences&marke5ng,Epidemiology&PublicHealth,Forecas5ng,Inventory&Logis5cmanagement
2. Manufacturing• Immunohematologyandtransfusionmicrobiologytes5ng,component
processingandcontractfrac5ona5on3. Clinicaltransfusionandlaboratorymedicine
• Bloodbanking,immunologyandlinkageswithInternalMedicine,Surgery,Paediatrics,O&Getc
• Importanceofqualitysystemthroughoutthetransfusionprocessanddesigna5onofQualityManagersinbloodcentres
DevelopmentofBTSinMalaysia(5)
Bloodcollec;on,MOH,2007-15
507,808527,898
565,604590,517
627,518646,890 653,124
675,315706,408
-
100,000
200,000
300,000
400,000
500,000
600,000
700,000
800,000
2007 2008 2009 2010 2011 2012 2013 2014 2015
KPIforTransfusionService:60%regulardona5ons
0
5000
10000
15000
20000
25000
30000
35000
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014Penang 0 0 0 0 0 0 0 0 0 0 0 0 0 0 618 504 462 672 648 292 598 115 266 280
Malacca 0 0 0 0 0 0 0 0 0 0 0 0 0 0 353 1352 2402 2660 2638 967 3266 2148 1410 2775
PDN 865 2630 0 4693 5275 6668 7241 9014 11786 12721 14125 18301 20214 22754 24801 27439 27474 27270 22844 25281 28326 19844 30674 30055
Berat(kg)
Year
VolumeofPlasmaforContractFrac;ona;on1991-2014
33,11032,350
22,107
32,190
26,54026,130
30,60230,338
29,295
25,772
22,754
20,214
18,301
14,125
12,72111,786
9,0147,241
6,668
5,2754,693
2,630
865
0.7%0.86%
30%
30%
1.%
4.50%
18%
0%
5%
10%
15%
20%
25%
30%
35%
1970 1980 1990 2000 2004 2005 2006
% of
repl
acem
ent d
onor
FAMILY REPLACEMENT DONORS - MALAYSIA
A dramatic drop in replacement donors between 1980 to 2006
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0
5
10
15
20
25
30
35
40
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014Seroconvert Prevalence(%)
Prevalence
SeroconvertNo.
Year
Seroprevalence of HIV & no of seroconvert among PDN’s blood donors
0
0.02
0.04
0.06
0.08
0.1
0.12
0
1
2
3
4
5
6
7
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Seroconvert Prevalence(%) Year
Sero
conv
ert N
o.
Prev
alenc
e (%
)
Seroprevalence of HCV & no of seroconvert among PDN’s blood donors
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0
2
4
6
8
10
12
14
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Ser
ocon
vert
No.
Seroconvert Prevalence(%)
Prev
alen
ce (%
)
Year Prev
alen
ce(%)
Seroprevalence of HBsAg & no of seroconvert among PDN’s blood donors
0
0.01
0.02
0.03
0.04
0.05
0.06
0.07
0.08
0.09
0
5
10
15
20
25
30
35
40
45
50
2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Seroconvert Prevalence(%)
Year
SeroconvertNo.
Prevalence(%)
Year
Seroprevalence of Syphillis & no of seroconvert among PDN’s blood donors
HIVRNA+,an5-HIV+concordant
NoHIVRNA–,an5-HIV+elitecontrollerswerefound
HIV-RNA An5-HIV
HIVinfec;onsofID-NATscreeningof1,722,885dona;onsCentralRegion(PDN,Selangor,WestPahang,NegeriSembilan)
(2008to2015)
694(95.7%)
HIVRNA+,an5-HIV–windowperiod
31(4.3%)
725 HIV infections (prevalence 0.04%) 31 HIV WP NAT yields (1:55,577)
ResidualTransmissionRisk:2.11permilliondona5ons@1in473,539dona5ons(ID50 (Virion):3.16)
HCVRNA+an5-HCV+
1374(86.7%)
HCVRNA+an5-HCV–15(0.95%)
HCVRNA–an5-HCV+196(12.37%)
HCV-RNA An5-HCV
1,585HCVinfec;ons(prevalence0.09%)15HCVWPNATyields(1:114,859)
HCVinfec;onsofID-NATscreeningof1,722,885dona;onsCentralRegion(PDN,Selangor,WestPahang,NegeriSembilan)
(2008to2015)
ResidualTransmissionRisk:0.18permilliondona5ons@1in5,592,957dona5ons
HBVDNA+HBsAg+
3,802(84.79%)
HBV-DNA+HBsAg–294(6.56%)
HBV-DNA–HBsAg+388(8.65%)
HBV-DNA HBsAg
4,484HBVinfec;ons(prevalence0.26%)104acutephaseWPNATyields(1:16,566)
190chronicOBINATyields(1:9,067)
HBVinfec;onsofID-NATscreeningof1,722,885dona;onsCentralRegion(PDN,Selangor,WestPahang,NegeriSembilan)
(2008to2015)
Es5matedResidualTransmissionRisk:5.50permilliondona5on@1in181,750dona5ons
Lessonslearnt
• Evolu5onofGMPimplementa5on-topdownapproachinthebeginningwithstrongleadershipwithinMOHandBTS
• Withdevelopmentofcri5calmassofspecialistsandHR-ownershipandimplementa5onofQMPatstateanddistrictlevel
• CultureofqualityindifferentcategoriesBTSstaff• Strategyandplanneedtobeinplace
Priorityforac5on• Productqualityandsafety-expansionofNATtocoverallblooddona5onandstrengtheningtheimplementa5onofQSincludingGMPinbloodcentres
• Pa5entsafetyduringtransfusionprocessandPa5entBloodManagement
• Blooddonorsafetyandsa5sfac5onfordonorreten5on• Increasingeffec5veness,efficiencyandreducingwastage
• Strengtheningofsystem–coordina5on,consolida5on,M&E,sustainabilityofopera5onalbudget,HRetc